FDA & Regulatory Policy | Friends of Cancer Research

You are here

FDA & Regulatory Policy

Letter to Commissioner Califf re: Centers of Excellence

28 organizations, including Friends of Cancer Research, have sent the below letter to FDA Commissioner Califf in support of the creation of an FDA Oncology Center of Excellence, providing detailed recommendations as to how this program might be carried out to most benefit patients.

Senate Appropriations Subcommittee Hearing with FDA Commissioner Margaret Hamburg

On Thursday, April 18, 2013, FDA Commissioner Margaret Hamburg appeared before the Senate Appropriations Committee, Subcommittee on Agriculture, Rural Development, the Food and Drug Administration, and Related Agencies to discuss the FDA's FY14 budget request.  Click here to access a summary of the hearing.

Alliance for A Stronger FDA Update: BA Monies, User Fees, and Related Complications for FY13

As described in a previously developed report, FDA will have about $74 million in new budget authority (BA, taxpayer) monies to spend in FY 13. However, the agency will lose ground in most areas because of the 2.513% rescission and the $126 million sequester of BA funds. Net/net, BA appropriations will decrease by about $117 million (4.7%), reflecting that Congress gave FDA extra funds sufficient to offset the rescission and slightly lessen the impact of the sequester.